{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:19:33Z","timestamp":1783055973842,"version":"3.54.6"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2023\/002978"],"award-info":[{"award-number":["CRG\/2023\/002978"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LS-I\/2020\/621"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2020\/621"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152766","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:16Z","timestamp":1779951616000},"page":"152766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting promoter G-quadruplex of SIRT3 with valsartan and candesartan as a therapeutic strategy to downregulate its expression in lung cancer"],"prefix":"10.1016","volume":"369","author":[{"given":"Pronamika","family":"Chetia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152766_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0015","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.0803790105","article-title":"A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis","volume":"105","author":"Ahn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","article-title":"The biochemistry of sirtuins","volume":"75","author":"Sauve","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0025","article-title":"Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0035","first-page":"80","article-title":"SIRT3 and cancer: tumor promoter or suppressor?","volume":"1816","author":"Alhazzazi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/1947601911417862","article-title":"The dual role of sirtuins in cancer","volume":"2","author":"Bosch-Presegu\u00e9","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0045","doi-asserted-by":"crossref","first-page":"43390","DOI":"10.18632\/oncotarget.9717","article-title":"Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia","volume":"7","author":"Qiao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0050","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s12253-020-00873-5","article-title":"Expression of SIRT1, SIRT3 and SIRT6 genes for predicting survival in triple-negative and hormone receptor-positive subtypes of breast cancer","volume":"26","author":"Uzelac","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jcb.25653","article-title":"SIRT3 silencing sensitizes breast cancer cells to cytotoxic treatments through an increment in ROS production","volume":"118","author":"Torrens-Mas","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0060","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3892\/ijo.2016.3767","article-title":"Sirtuin 3: a Janus face in cancer (Review)","volume":"49","author":"Xiong","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0065","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/jca.53173","article-title":"Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells","volume":"12","author":"Cao","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10735-022-10075-9","article-title":"CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1","volume":"53","author":"Wang","year":"2022","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00432-017-2537-9","article-title":"SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer","volume":"144","author":"Xiong","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0080","article-title":"The role and therapeutic perspectives of sirtuin 3 in cancer metabolism reprogramming, metastasis, and chemoresistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0085","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"Burge","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188410","article-title":"Human MYC G-quadruplex: from discovery to a cancer therapeutic target","volume":"1874","author":"Wang","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trechm.2019.07.002","article-title":"The structure and function of DNA G-quadruplexes","volume":"2","author":"Spiegel","year":"2020","journal-title":"Trends Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.tibtech.2017.06.012","article-title":"G-quadruplexes: prediction, characterization, and biological application","volume":"35","author":"Kwok","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41580-020-0236-x","article-title":"The regulation and functions of DNA and RNA G-quadruplexes","volume":"21","author":"Varshney","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0110","first-page":"863","article-title":"Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer","volume":"20","author":"Tabatabai","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0115","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s13346-020-00842-0","article-title":"Candesartan treatment enhances liposome penetration and anti-tumor effect via depletion of tumor stroma and normalization of tumor vessel","volume":"11","author":"Cai","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/atm-22-2108","article-title":"Candesartan induces tumor vascular normalization to improve the efficacy of radiotherapy in the therapeutic window","volume":"10","author":"Zhu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/jpet.114.216382","article-title":"Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis","volume":"350","author":"Alhusban","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0130","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/cncr.33391","article-title":"Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K\/AKT signaling in nasopharyngeal carcinoma","volume":"127","author":"Lin","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115951","article-title":"Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer","volume":"440","author":"Asgharzadeh","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/D0NJ02937H","article-title":"Candesartan and valsartan Zn(II) complexes as inducing agents of reductive stress: mitochondrial dysfunction and apoptosis","volume":"45","author":"Mart\u00ednez","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/CEJ.0b013e32832f9c00","article-title":"Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation","volume":"18","author":"Wang","year":"2009","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026739","article-title":"N-nitrosodimethylamine-contaminated valsartan and risk of cancer: a nationwide study of 1.4 million valsartan users","volume":"11","author":"Mansouri","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102245","article-title":"Cancer risk associated with the use of valsartan in Korea: a nationwide cohort study","volume":"80","author":"Jeon","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0160","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jmb.2017.06.013","article-title":"3D-NuS: a web server for automated modeling and visualization of non-canonical three-dimensional nucleic acid structures","volume":"429","author":"Patro","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0165","doi-asserted-by":"crossref","first-page":"25673","DOI":"10.1039\/C8RA03708F","article-title":"Fluorescence-based tools to probe G-quadruplexes in cell-free and cellular environments","volume":"8","author":"Manna","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0170","article-title":"Carbazole derivatives\u2019 binding to c-KIT G-quadruplex DNA","volume":"23","author":"G\u0142uszy\u0144ska","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0175","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1021\/bi4006072","article-title":"Multiple and cooperative binding of fluorescence light-up probe thioflavin T with human telomere DNA G-quadruplex","volume":"52","author":"Gabelica","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0180","series-title":"G-Quadruplex Nucleic Acids Methods Protoc","first-page":"157","article-title":"NMR studies of G-quadruplex structures and G-quadruplex-interactive compounds","author":"Lin","year":"2019"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2012.05.003","article-title":"NMR spectroscopy of G-quadruplexes","volume":"57","author":"Adrian","year":"2012","journal-title":"Methods San Diego Calif"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0190","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/cbic.202100127","article-title":"Thermodynamic stability of G-quadruplexes: impact of sequence and environment","volume":"22","author":"Jana","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0195","doi-asserted-by":"crossref","first-page":"10799","DOI":"10.1021\/ja010008o","article-title":"Folding of the thrombin aptamer into a G-quadruplex with Sr2+: stability, heat, and hydration","volume":"123","author":"Kankia","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0200","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1021\/acs.jpcb.6b03731","article-title":"Ionic effects on VEGF G-quadruplex stability","volume":"120","author":"Kim","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0205","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/nar\/9.13.3047","article-title":"A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system+","volume":"9","author":"Garner","year":"1981","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0210","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nsmb982","article-title":"Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo","volume":"12","author":"Paeschke","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0215","first-page":"18","article-title":"Experimental strategies for the identification of DNA-binding proteins","volume":"2012","author":"Carey","year":"2012","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-9666-7_11","article-title":"Electrophoretic mobility shift assay and dimethyl sulfate footprinting for characterization of G-quadruplexes and G-quadruplex-protein complexes","volume":"2035","author":"Onel","year":"2019","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1039\/B714772B","article-title":"A hitchhiker\u2019s guide to G-quadruplex ligands","volume":"6","author":"Monchaud","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0240","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.081560598","article-title":"Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors","volume":"98","author":"Read","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0245","first-page":"37","article-title":"Molecular dynamics simulations: advances and applications","volume":"8","author":"Hospital","year":"2015","journal-title":"Adv. Appl. Bioinforma. Chem. AABC"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0250","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.tibtech.2017.06.012","article-title":"G-quadruplexes: prediction, characterization, and biological application","volume":"35","author":"Kwok","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04791-x","article-title":"The effect of prolonged G-quadruplex stabilization on the functions of human cells","volume":"15","author":"Karatayeva","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0260","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1039\/D5CB00024F","article-title":"A state-of-the-art view: G-quadruplex-targeting for platinum complexes\u2019 treatment of tumors","volume":"6","author":"Yang","year":"2025","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0265","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/0006-2952(90)90364-Q","article-title":"An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines","volume":"40","author":"Hosking","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0270","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/1871520616666160404110953","article-title":"Differential cytotoxicity, cellular uptake, apoptosis and inhibition of BRCA1 expression of BRCA1-defective and sporadic breast cancer cells induced by an anticancer ruthenium(II)-arene compound, RAPTA-EA1","volume":"17","author":"Ratanaphan","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0275","first-page":"1329","article-title":"Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression","volume":"27","author":"Li","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","article-title":"The significance of cancer cell expression of the chemokine receptor CXCR4","volume":"14","author":"Balkwill","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0290","doi-asserted-by":"crossref","first-page":"12124","DOI":"10.1093\/nar\/gkad948","article-title":"Genetic variations in G-quadruplex forming sequences affect the transcription of human disease-related genes","volume":"51","author":"Lorenzatti","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0295","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1093\/nar\/gkab609","article-title":"DNA G-quadruplex structures: more than simple roadblocks to transcription?","volume":"49","author":"Robinson","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0300","doi-asserted-by":"crossref","DOI":"10.1080\/21690731.2016.1244031","article-title":"RNA G-quadruplexes and their potential regulatory roles in translation","volume":"4","author":"Song","year":"2016","journal-title":"Translation"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118209","article-title":"Discovery of Y502-2304, a potent c-Myc G-quadruplex stabilizer for the treatment of multiple myeloma","volume":"301","author":"Gao","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0310","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchem.1548","article-title":"Quantitative visualization of DNA G-quadruplex structures in human cells","volume":"5","author":"Biffi","year":"2013","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0315","series-title":"Resveratrol Targets G-quadruplexes to Exert its Pharmacological Effects","author":"Soriano-Lerma","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110753","article-title":"G-Quadruplex\u2013specific action of chloroquine-based immunomodulator drugs to inhibit the cancer progression","volume":"301","author":"Sarkar","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115951","article-title":"Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer","volume":"440","author":"Asgharzadeh","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122939","article-title":"Valsartan as a prophylactic treatment against breast cancer development and niche activation: what molecular sequels follow chronic AT-1R blockade?","volume":"353","author":"Mansour","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0335","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4161\/cbt.21353","article-title":"Cancer cell spheroids as a model to evaluate chemotherapy protocols","volume":"13","author":"Perche","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11538-020-00746-7","article-title":"Comparison of drug inhibitory effects (IC50) in monolayer and spheroid cultures","volume":"82","author":"Berrouet","year":"2020","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0345","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2020.08.075","article-title":"Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines","volume":"533","author":"Muguruma","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0350","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3390\/cancers15194846","article-title":"Three-dimensional in vitro tumor spheroid models for evaluation of anticancer therapy: recent updates","volume":"15","author":"Nayak","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0355","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/biomedicines11041058","article-title":"Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3D in vitro cancer models in the drug efficacy assessment","volume":"11","author":"Tosca","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/foods13040564","article-title":"Comparative study of spheroids (3D) and monolayer cultures (2D) for the in vitro assessment of cytotoxicity induced by the mycotoxins Sterigmatocystin, Ochratoxin A and Patulin","volume":"13","author":"Zingales","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45144-w","article-title":"Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations","volume":"13","author":"Abbas","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0370","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/ijms23031166","article-title":"Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and rcc models","volume":"23","author":"Filipiak-Duliban","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0375","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2147\/DDDT.S108004","article-title":"Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells","volume":"10","author":"Baek","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0380","unstructured":"X. Pei, Multicellular spheroids of A549 and A549-iRFP as an in vitro model of lung cancer, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0385","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/s41598-019-41273-3","article-title":"Effect of spheroidal age on sorafenib diffusivity and toxicity in a 3D HepG2 spheroid model","volume":"9","author":"Eilenberger","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0390","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/ijo.2016.3376","article-title":"Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics","volume":"48","author":"Meenach","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0395","article-title":"A549 alveolar carcinoma spheroids as a cytotoxicity platform for carboxyl- and amine-polyethylene glycol gold nanoparticles","volume":"13","author":"Petzer","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/jpm13020243","article-title":"Angiotensin receptor blocker associated with a decreased risk of lung cancer: an updated meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0405","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.18632\/oncotarget.28134","article-title":"Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052\/484 spheroids","volume":"12","author":"Gendre","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.791069","article-title":"Biomedical applications of non-small cell lung cancer spheroids","volume":"11","author":"Rozenberg","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109384","article-title":"NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death","volume":"27","author":"Debsharma","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0420","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.jmedchem.3c01979","article-title":"SIRT3 activation a promise in drug development? New insights into SIRT3 biology and its implications on the drug discovery process","volume":"67","author":"Lambona","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0425","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1073\/pnas.182256799","article-title":"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription","volume":"99","author":"Siddiqui-Jain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0430","doi-asserted-by":"crossref","first-page":"W676","DOI":"10.1093\/nar\/gkl253","article-title":"QGRS mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences","volume":"34","author":"Kikin","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0435","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymeth.2021.12.005","article-title":"Biochemical analysis of DNA synthesis blockage by G-quadruplex structure and bypass facilitated by a G4-resolving helicase","volume":"204","author":"Sommers","year":"2022","journal-title":"Methods San Diego Calif"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0440","unstructured":"BG4 antibody can recognize telomeric G-quadruplexes harboring destabilizing base modifications and lesions - PMC, (n.d.). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10939409\/ (accessed February 14, 2026)."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0445","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4939-9666-7_9","article-title":"NMR studies of g-quadruplex structures and g-quadruplex-interactive compounds","volume":"2035","author":"Lin","year":"2019","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.871560","article-title":"The double-edged sword of SIRT3 in cancer and its therapeutic applications","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0455","series-title":"G-Quadruplex Mediated c-myc Specific Downregulation: A Unique Pathway of the Anticancer Action of Immunomodulator Drugs","author":"Sarkar","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.152766_bb0460","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/biomedicines11030969","article-title":"G-quadruplexes in c-MYC promoter as targets for cancer therapy","volume":"11","author":"Bahls","year":"2023","journal-title":"Biomedicines"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026026930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:52:44Z","timestamp":1783054364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026026930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":92,"alternative-id":["S0141813026026930"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152766","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting promoter G-quadruplex of SIRT3 with valsartan and candesartan as a therapeutic strategy to downregulate its expression in lung cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152766"}}